Multidisciplinary Content Validation of the GiriMok Point-of-Care Protocol for Neonatal Cyanotic Congenital Heart

Girish Gupta1, Syed Moiz Ahmed1, Richa Joshi2

  • 1Neonatology, Graphic Era Institute of Medical Sciences, Dehradun, IND.

Cureus
|June 29, 2026
PubMed

Insights

The GiriMok Protocol, a new point-of-care tool for neonatal cyanotic congenital heart disease, achieved unanimous expert validation. This validated protocol is ready for clinical evaluation as a critical decision-support tool.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Emergency Medicine

Background:

  • Neonatal cyanotic congenital heart disease presents a time-critical emergency.
  • Existing guidelines lack a validated point-of-care (POC) protocol for frontline clinicians.
  • The GiriMok Protocol was developed to address this critical need in diverse clinical settings.

Purpose of the Study:

  • To develop and establish the content validity of the GiriMok POC Protocol.
  • To ensure the protocol is suitable for immediate bedside decision-making by frontline clinicians.
  • To create a rigorous, expert-validated decision-support tool for neonatal emergencies.

Main Methods:

  • A four-phase iterative, multidisciplinary expert validation process was employed.
  • Phase 1 involved 18 experts assessing 33 parameters; Phase 2 involved 5 specialists revalidating a 16-item instrument.
  • Content Validity Index (CVI) and modified kappa (k*) were used to measure validity, with subsequent guideline-based enhancements.

Main Results:

  • Phase 1 yielded a Scale-CVI/Ave of 0.927, with all items meeting validity thresholds and no safety concerns.
  • Phase 2 achieved perfect scores (S-CVI/Ave = k* = 1.000) after integrating expert feedback and revisions.
  • 35 expert-informed corrections led to the final GiriMok V4.0, demonstrating unanimous multidisciplinary validation.

Conclusions:

  • The GiriMok POC Protocol successfully achieved unanimous multidisciplinary content validation.
  • The perfect Phase 2 CVI underscores the protocol's methodological rigor and responsiveness to expert input.
  • The validated GiriMok Protocol is poised for prospective clinical evaluation and national dissemination as a neonatal emergency decision-support tool.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...